Cargando…

PPARdelta in Affected Atopic Dermatitis and Psoriasis: A Possible Role in Metabolic Reprograming

Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors expressed in the skin. Three PPAR isotypes, α (NRC1C1), β or δ (NRC1C2) and γ (NRC1C3), have been identified. After activation through ligand binding, PPARs heterodimerize with the 9-cis-retinoic acid receptor (RXR), a...

Descripción completa

Detalles Bibliográficos
Autores principales: Blunder, Stefan, Pavel, Petra, Minzaghi, Deborah, Dubrac, Sandrine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303290/
https://www.ncbi.nlm.nih.gov/pubmed/34298981
http://dx.doi.org/10.3390/ijms22147354
_version_ 1783727051388223488
author Blunder, Stefan
Pavel, Petra
Minzaghi, Deborah
Dubrac, Sandrine
author_facet Blunder, Stefan
Pavel, Petra
Minzaghi, Deborah
Dubrac, Sandrine
author_sort Blunder, Stefan
collection PubMed
description Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors expressed in the skin. Three PPAR isotypes, α (NRC1C1), β or δ (NRC1C2) and γ (NRC1C3), have been identified. After activation through ligand binding, PPARs heterodimerize with the 9-cis-retinoic acid receptor (RXR), another nuclear hormone receptor, to bind to specific PPAR-responsive elements in regulatory regions of target genes mainly involved in organogenesis, cell proliferation, cell differentiation, inflammation and metabolism of lipids or carbohydrates. Endogenous PPAR ligands are fatty acids and fatty acid metabolites. In past years, much emphasis has been given to PPARα and γ in skin diseases. PPARβ/δ is the least studied PPAR family member in the skin despite its key role in several important pathways regulating inflammation, keratinocyte proliferation and differentiation, metabolism and the oxidative stress response. This review focuses on the role of PPARβ/δ in keratinocytes and its involvement in psoriasis and atopic dermatitis. Moreover, the relevance of targeting PPARβ/δ to alleviate skin inflammation is discussed.
format Online
Article
Text
id pubmed-8303290
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83032902021-07-25 PPARdelta in Affected Atopic Dermatitis and Psoriasis: A Possible Role in Metabolic Reprograming Blunder, Stefan Pavel, Petra Minzaghi, Deborah Dubrac, Sandrine Int J Mol Sci Review Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors expressed in the skin. Three PPAR isotypes, α (NRC1C1), β or δ (NRC1C2) and γ (NRC1C3), have been identified. After activation through ligand binding, PPARs heterodimerize with the 9-cis-retinoic acid receptor (RXR), another nuclear hormone receptor, to bind to specific PPAR-responsive elements in regulatory regions of target genes mainly involved in organogenesis, cell proliferation, cell differentiation, inflammation and metabolism of lipids or carbohydrates. Endogenous PPAR ligands are fatty acids and fatty acid metabolites. In past years, much emphasis has been given to PPARα and γ in skin diseases. PPARβ/δ is the least studied PPAR family member in the skin despite its key role in several important pathways regulating inflammation, keratinocyte proliferation and differentiation, metabolism and the oxidative stress response. This review focuses on the role of PPARβ/δ in keratinocytes and its involvement in psoriasis and atopic dermatitis. Moreover, the relevance of targeting PPARβ/δ to alleviate skin inflammation is discussed. MDPI 2021-07-08 /pmc/articles/PMC8303290/ /pubmed/34298981 http://dx.doi.org/10.3390/ijms22147354 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Blunder, Stefan
Pavel, Petra
Minzaghi, Deborah
Dubrac, Sandrine
PPARdelta in Affected Atopic Dermatitis and Psoriasis: A Possible Role in Metabolic Reprograming
title PPARdelta in Affected Atopic Dermatitis and Psoriasis: A Possible Role in Metabolic Reprograming
title_full PPARdelta in Affected Atopic Dermatitis and Psoriasis: A Possible Role in Metabolic Reprograming
title_fullStr PPARdelta in Affected Atopic Dermatitis and Psoriasis: A Possible Role in Metabolic Reprograming
title_full_unstemmed PPARdelta in Affected Atopic Dermatitis and Psoriasis: A Possible Role in Metabolic Reprograming
title_short PPARdelta in Affected Atopic Dermatitis and Psoriasis: A Possible Role in Metabolic Reprograming
title_sort ppardelta in affected atopic dermatitis and psoriasis: a possible role in metabolic reprograming
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303290/
https://www.ncbi.nlm.nih.gov/pubmed/34298981
http://dx.doi.org/10.3390/ijms22147354
work_keys_str_mv AT blunderstefan ppardeltainaffectedatopicdermatitisandpsoriasisapossibleroleinmetabolicreprograming
AT pavelpetra ppardeltainaffectedatopicdermatitisandpsoriasisapossibleroleinmetabolicreprograming
AT minzaghideborah ppardeltainaffectedatopicdermatitisandpsoriasisapossibleroleinmetabolicreprograming
AT dubracsandrine ppardeltainaffectedatopicdermatitisandpsoriasisapossibleroleinmetabolicreprograming